- Home
- VEEE vs WINT Comparison
VEEE vs WINT Comparison
Compare VEEE & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- WINT
- Stock Information
- Founded
- VEEE 1994
- WINT 1992
- Country
- VEEE United States
- WINT United States
- Employees
- VEEE N/A
- WINT N/A
- Industry
- VEEE Marine Transportation
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VEEE Industrials
- WINT Health Care
- Exchange
- VEEE Nasdaq
- WINT Nasdaq
- Market Cap
- VEEE 4.7M
- WINT 5.3M
- IPO Year
- VEEE 2021
- WINT 1995
- Fundamental
- Price
- VEEE $0.44
- WINT $0.48
- Analyst Decision
- VEEE
- WINT Hold
- Analyst Count
- VEEE 0
- WINT 1
- Target Price
- VEEE N/A
- WINT $18.00
- AVG Volume (30 Days)
- VEEE 1.3M
- WINT 1.9M
- Earning Date
- VEEE 11-14-2024
- WINT 11-26-2024
- Dividend Yield
- VEEE N/A
- WINT N/A
- EPS Growth
- VEEE N/A
- WINT N/A
- EPS
- VEEE N/A
- WINT N/A
- Revenue
- VEEE $20,852,002.00
- WINT N/A
- Revenue This Year
- VEEE $76.99
- WINT N/A
- Revenue Next Year
- VEEE N/A
- WINT N/A
- P/E Ratio
- VEEE N/A
- WINT N/A
- Revenue Growth
- VEEE N/A
- WINT N/A
- 52 Week Low
- VEEE $0.33
- WINT $0.45
- 52 Week High
- VEEE $1.77
- WINT $22.32
- Technical
- Relative Strength Index (RSI)
- VEEE 39.83
- WINT 24.83
- Support Level
- VEEE $0.44
- WINT $0.53
- Resistance Level
- VEEE $0.52
- WINT $0.64
- Average True Range (ATR)
- VEEE 0.06
- WINT 0.07
- MACD
- VEEE -0.00
- WINT 0.08
- Stochastic Oscillator
- VEEE 15.69
- WINT 6.24
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.